This page is also available in:
Français
Complete a short questionnaire about a condition that you or a loved one may have, and find out if you (or they) might qualify for a clinical research study that could help improve your health.
Take Our Study Questionnaire for ongoing clinical research studies
Canadian Health & Wellness
Explore health guides on various medical conditions, news about drug development, regulatory updates from Health Canada and the FDA, and other health-related topics we think you’ll find valuable.
This page is also available in: Français Curious about the science behind today’s most talked-about diabetes and weight-management treatments? Our new, four-part blog series on GLP-1 Agonists will break down everything you need to know — from how these drugs work, to their real-world results, side effects, and what’s coming next in the pipeline. Today,
Read More
This page is also available in: Français Following the success of Ozempic®, Wegovy®, and other GLP-1 receptor agonists, pharmaceutical companies are racing to develop the next wave of metabolic drugs. These new therapies build on the proven benefits of currently approved GLP-1s—lowering blood sugar, supporting weight loss, and reducing cardiovascular risk—while aiming for even greater
Read More
This page is also available in: Français Curious about the science behind today’s most talked-about diabetes and weight-management treatments? Our new, four-part blog series on GLP-1 Agonists will break down everything you need to know — from how these drugs work, to their real-world results, side effects, and what’s coming next in the pipeline. Today, we’re
Read More
This page is also available in: Français Curious about the science behind today’s most talked-about diabetes and weight-management treatments? Our new, four-part blog series on GLP-1 Agonists will break down everything you need to know — from how these drugs work, to their real-world results, side effects, and what’s coming next in the pipeline. GLP-1
Read More
This page is also available in: Français The mRNA technology behind the COVID-19 vaccines that saved millions of lives during the pandemic may also help fight cancer, according to new research published in Nature. Scientists found that the Pfizer and Moderna mRNA vaccines can strengthen the immune system’s ability to recognize and kill tumor cells,
Read More
This page is also available in: Français Eli Lilly’s diabetes drug Mounjaro (tirzepatide) is moving closer to approval for children and teens after strong results from a new clinical trial. The phase 3 SURPASS-PEDS study tested the drug in 99 patients ages 10 to 17 who struggled to control their blood sugar with common treatments
Read More
This page is also available in: Français A groundbreaking study from the University of Auckland has found that a single fecal microbiota transplant (FMT) can provide obese teenagers with years of health benefits. FMT involves transferring gut bacteria from healthy donors to patients—in this case, through capsules swallowed over two days. While the idea may
Read More
This page is also available in: Français Eli Lilly is moving closer to bringing its experimental weight loss pill, orforglipron, to market after releasing positive results from its latest phase 3 clinical trial. The study, called Attain-2, tested the once-daily pill in people who are overweight or obese and also have Type 2 diabetes—a group
Read More
This page is also available in: Français Novo Nordisk’s popular weight-loss drug Wegovy has just received a new approval from the U.S. Food and Drug Administration (FDA)—this time for treating a serious liver condition called metabolic dysfunction-associated steatohepatitis (MASH). This marks Wegovy’s third approved use, following its approvals for obesity and reducing cardiovascular risk. MASH,
Read More
This page is also available in: Français The availability of COVID-19 vaccines for young children in the U.S. could shrink this fall as the Food and Drug Administration (FDA) considers ending the emergency use authorization (EUA) for Pfizer-BioNTech’s vaccine in kids ages 6 months to 4 years. Pfizer says it is in discussions with the
Read More
This page is also available in: Français A large new study suggests that verbal abuse during childhood can be just as harmful to long-term mental health as physical abuse—and in some cases, even worse. Researchers from Liverpool John Moores University analyzed data from over 20,000 adults in England and Wales collected between 2012 and 2024.
Read More
This page is also available in: Français A major new study has found that drinking just one can of diet soda a day may raise your risk of developing type 2 diabetes by 38%. Surprisingly, this is a greater risk than what’s seen with regular sugary sodas. The study, led by researchers at Monash University,
Read More
This page is also available in: Français A recent clinical trial is offering new hope in the fight against HIV. Researchers tested a new type of vaccine using mRNA technology—the same method used in COVID-19 vaccines—to see if it could trigger strong immune responses against the virus. The trial, called HVTN 302, tested three different
Read More
This page is also available in: Français A major new study from Denmark shows no link between aluminum in childhood vaccines and an increased risk of diseases like asthma or autism. Researchers examined health and vaccination records of over 1.2 million children from 1997 to 2018. They found no evidence that aluminum-containing vaccines cause harm.
Read More
This page is also available in: Français The FDA has approved a safer dosing schedule for Eli Lilly’s Alzheimer’s drug, Kisunla, which could make it more appealing to doctors and patients. The updated schedule reduces the risk of a serious side effect called ARIA-E—brain swelling caused by anti-amyloid drugs. Originally, Kisunla was given in higher
Read More
This page is also available in: Français Over the past 50 years, vaccines have saved millions of children’s lives by protecting them from deadly diseases like measles, polio, and diphtheria. But a major new study shows this progress is now stalling—and even reversing in some countries—putting millions of children worldwide at risk. The study, led
Read More
JoinAStudy.ca is your trusted resource, created by a network of Canadian physicians dedicated to advancing medicine through clinical research. We are committed to providing reliable health information and making it easier for you to participate in clinical trials.
The JoinAStudy community includes individuals who have participated in clinical research studies with our physicians or those interested in joining a study and receiving health-related updates. Why not join us?
Clinical research plays a vital role in advancing healthcare. By joining a study, you have the opportunity to:
- Make a Difference: Contribute to medical breakthroughs that benefit yourself and future generations.
- Gain Early Access to New Treatments: Be among the first to access potential new medications or treatments not yet widely available.
- Deepen Your Health Knowledge: Learn more about your specific condition and receive comprehensive medical care throughout the study.
- Contribute to Your Well-being: Receive additional medical attention and potentially improve your health through participation.
JoinAStudy is more than a research platform—it’s a community built on trust and dedication. Our study participants are the unsung heroes who drive medical progress forward. By joining our trusted community, you’ll receive updates on studies that may benefit you, your family, or friends. Whether or not there’s a study right for you now, you’ll be the first to know when new opportunities arise. And remember, you can leave our community anytime – just let us know, and we’ll respect your choice.
I haven’t actually started the study for Knee Osteoarthritis��Pain and have already experienced a positive outcome.
While going through the initial interview, I mentioned I had been diagnosed with alcohol-induced fatty liver disease, but had been trying to reverse the damage by not consuming alcohol and by taking supplements to��support my��liver. The results of my required blood test came back and, amazing news, my liver function is now normal and even if I wasn’t accepted into the study I felt I had already received great benefit by receiving this news.
Vancouver, British Columbia -
I was very fortunate to participate in a clinical research study, not only because I have benefited from a new cholesterol-reducing drug, but also because of the relationship with the doctor’s office that developed out of the trial led to the early detection and treatment of a heart condition that might otherwise have been fatal in a few years.
Woodstock, Ontario -
I have participated in many asthma clinical research studies. You really feel like they [study staff] care about your health and they are there to provide support and suggestions regarding your health such as new drugs that may help you down the road. That is why I participate in these studies because I am always looking to improve my health.
Newmarket, Ontario -
The clinical trial I participated in was a very rewarding experience. The drug I was trailing was a positive for my condition. My provider of the study was very knowledgeable and extremely helpful. My appointments were always on time and conducted with the utmost care. A job well done.
Woodstock, Ontario -
Please note that these testimonials describe the experiences of a few study participants and may not accurately describe your experience.
